These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 794415)

  • 21. Mouse spleen cell-derived toxoplasma growth inhibitory factor: its separation from macrophage migration inhibitory factor.
    Nagasawa H; Igarashi I; Matsumoto T; Sakurai H; Marbella C; Suzuki N
    Immunobiology; 1980 Dec; 157(4-5):307-19. PubMed ID: 7005083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased responsiveness to macrophage-activating factor (MAF) after alteration of macrophage membranes.
    Piessens WF; Remold HG; David JR
    J Immunol; 1977 Jun; 118(6):2078-82. PubMed ID: 325137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of stimulated lymphocyte supernatants on the electrophoretic mobility distribution of peritoneal macrophages.
    Petty HR; Ware BR; Remold HG; Rocklin RE
    J Immunol; 1980 Jan; 124(1):381-7. PubMed ID: 6153099
    [No Abstract]   [Full Text] [Related]  

  • 24. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
    Rocklin RE
    J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
    [No Abstract]   [Full Text] [Related]  

  • 25. Desensitization: effects on cutaneous and peritoneal manifestations of delayed hypersensitivity in relation to lymphokine production.
    Sonozaki H; Papermaster V; Yoshida T; Cohen S
    J Immunol; 1975 Dec; 115(6):1657-61. PubMed ID: 1102607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphokines. VI. Factors in human and other heterologous sera inhibiting the migration of guinea pig macrophages.
    Baer R; Vogt K; Lazary S; Geczy C; de Weck AL
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):130-43. PubMed ID: 746681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on human migration inhibitory factor: characterization of three molecular species.
    Weiser WY; Greineder DK; Remold HG; David JR
    J Immunol; 1981 May; 126(5):1958-62. PubMed ID: 7012240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants.
    Cohen MC; Zeschke R; Bigazzi PE; Yoshida T; Cohen S
    J Immunol; 1975 May; 114(5):1641-3. PubMed ID: 164509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible role of macrophage glycolipids as receptors for migration inhibitory factor (MIF).
    Higgins TJ; Sabatino AP; Remold HG; David JR
    J Immunol; 1978 Sep; 121(3):880-6. PubMed ID: 357658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An assay for macrophage activating factor based on the adherence of oil-elicited guinea pig macrophages: characterization of a lymphokine-induced release of hydrogen peroxide from elicited macrophages.
    Talmadge KW; Peck R
    Lymphokine Res; 1986; 5(1):35-47. PubMed ID: 3511329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte chemotaxis in inflammation. VII. Isolation and purification of chemotactic factors for T lymphocytes from PPD-induced delayed hypersensitivity skin reaction site in the guinea-pig.
    Shimokawa Y; Harita S; Hayashi H
    Immunology; 1984 Feb; 51(2):275-85. PubMed ID: 6607210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures.
    Friedrich W; Lazary S; Geczy C; de Weck AL
    Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparsion of the properties of two antigen-induced guinea pig lymphokines.
    Ashworth LA; Eckersley BJ; Ford WH
    Int Arch Allergy Appl Immunol; 1975; 48(1):143-55. PubMed ID: 46849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen handling by guinea pig macrophages: further evidence for the sequestration of antigen relevant for activation of primed T lymphocytes.
    Ellner JJ; Lipsky PE; Rosenthal AS
    J Immunol; 1977 Jun; 118(6):2053-7. PubMed ID: 325135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologically mediated macrophage aggregation in monolayers of peritoneal cells from BCG-sensitized mice.
    Preston PM; Hart PD; Brown IN
    Immunology; 1977 Jan; 32(1):33-41. PubMed ID: 139359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monocyte procoagulant inducing factor: a lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen.
    Gregory SA; Kornbluth RS; Helin H; Remold HG; Edgington TS
    J Immunol; 1986 Nov; 137(10):3231-9. PubMed ID: 2945864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.
    Thomson AW; Moon DK; Geczy CL; Nelson DS
    Immunology; 1983 Feb; 48(2):291-9. PubMed ID: 6337088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to guinea pig lymphokines. VII. Reactivity with products of lymphoid and nonlymphoid cells.
    Sorg C; Geczy CL
    J Immunol; 1978 Sep; 121(3):1199-205. PubMed ID: 99476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro.
    Geczy CL; Hopper KE
    J Immunol; 1981 Mar; 126(3):1059-65. PubMed ID: 7462626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.
    Center DM; Cruikshank WW; Berman JS; Beer DJ
    J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.